MENU

MPLT MapLight Therapeutics Inc. Chart, History Price & Graph

MPLT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Last 5 trading days

MapLight Therapeutics, Inc. (MPLT) Price Chart Analysis: Trend, Key Levels, and Technical Signals

Key Takeaways

  • MPLT exhibits an overall uptrend since its IPO, with shares surging approximately 78% over the past month amid high volatility.
  • Short-term price action shows consolidation below key moving averages, with recent pullback from highs near $32.
  • Key support cluster at $27.55–$28.18; resistance at $29.49–$30.17.
  • RSI(14) at 37 indicates selling pressure nearing oversold territory; MACD shows a mild buy signal at 0.01.
  • Price trading below 50-day MA ($28.92) but above 100-day ($26.95) and 200-day ($22.75) MAs, signaling potential long-term bullish bias.

Trend Analysis

The chart of MPLT reflects a robust uptrend from its October 2025 IPO debut around $17, propelled by biotech sector momentum and positive analyst coverage. Over the last quarter, shares have climbed significantly, posting year-to-date gains exceeding 84%. However, the past 30 days have seen heightened volatility, with a sharp rally followed by consolidation and a pullback from recent peaks above $31. This forms a classic post-rally breathing pattern, with price action respecting an ascending channel from IPO lows. Trader discussions highlight a potential falling wedge resolution earlier in the upmove, now evolving into sideways trading near $28.

Support and Resistance Levels

Critical support levels cluster around $27.55 (S2 pivot) and $28.18 (S1), aligning with recent lows and the 50-day MA. Deeper support at $26.86 (S3) coincides with prior consolidation zones. Resistance begins at $29.49 (R1), tested multiple times recently, followed by $30.17 (R2) and $30.80 (R3), near prior highs. These pivot-derived levels, based on classic methodology, serve as focal points for intraday and swing traders, with breaks potentially signaling directional shifts.

Moving Averages

Short-term moving averages present a bearish alignment, with price below the 5-day ($28.88), 10-day ($30.30), 20-day ($29.84), and 50-day simple MAs ($28.92), all flashing sell signals. Exponential MAs reinforce this, trading similarly higher. Conversely, longer-term MAs remain supportive: 100-day at $26.95 (buy) and 200-day at $22.75 (buy). This golden cross-like setup between short- and long-term averages underscores the prevailing uptrend resilience amid near-term weakness.

Momentum Indicators

RSI(14) reading of 37 suggests bearish momentum but approaches oversold levels, complemented by Stochastic (27.25, sell) and Williams %R (-99.91, oversold). MACD(12,26) at 0.01 generates a subtle buy signal, hinting at possible divergence from price lows. ADX(14) at 43.78 indicates a strong downtrend component short-term, while high ATR(1.21) confirms elevated volatility typical for post-IPO biotechs.

AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast datasets including technical indicators, price patterns, and historical trends for MPLT. These signals identify potential buy or sell opportunities by recognizing recurring market behaviors, trend shifts, and momentum divergences. Traders rely on them to pinpoint entry/exit points, validate chart setups, and enhance decision-making amid volatility. Explore the signals for real-time insights tailored to your strategy.

Technical Outlook and Key Levels to Watch

Traders eye a hold above $27.55 support for continuation toward $30 resistance, where a breakout could retest recent highs. Failure here risks probing $26.86, potentially accelerating downside. Monitor RSI for oversold bounces, MACD crossovers, and volume for confirmation. Longer-term, sustained price above 100-day MA supports bullish structure, with biotech catalysts influencing near-term swings.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

View a ticker or compare two or three
MPLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
MapLight Therapeutics, Inc. (MPLT) Price Chart Analysis: Trend, Key Levels, and Technical Signals